Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

被引:0
|
作者
Van Der Meeren, Olivier [1 ]
Crasta, Priya [2 ]
Cheuvart, Brigitte [1 ]
De Ridder, Marc [1 ]
机构
[1] GSK Vaccines, Wavre, Belgium
[2] GSK Vaccines, Bangalore, Karnataka, India
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1726 / 1728
页数:3
相关论文
共 50 条
  • [11] Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults
    Van Damme, Pierre
    Minervini, Gianmaria
    Liss, Charles L.
    McCarson, Barbara
    Vesikari, Timo
    Boslego, John W.
    Bhuyan, Prakash K.
    HUMAN VACCINES, 2009, 5 (02): : 92 - 97
  • [12] CLINICAL-EVALUATION IN HEALTHY-ADULTS OF A HEPATITIS-B VACCINE MADE BY RECOMBINANT DNA
    SCOLNICK, EM
    MCLEAN, AA
    WEST, DJ
    MCALEER, WJ
    MILLER, WJ
    BUYNAK, EB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (21): : 2812 - 2815
  • [13] THE IMMUNE-RESPONSE OF HEALTHY-ADULTS TO A REDUCED DOSE OF HEPATITIS-B VACCINE
    SZMUNESS, W
    STEVENS, CE
    HARLEY, EJ
    ZANG, EA
    TAYLOR, PE
    ALTER, HJ
    JOURNAL OF MEDICAL VIROLOGY, 1981, 8 (02) : 123 - 129
  • [14] IMMUNOGENICITY OF A LOW-DOSE RECOMBINANT DNA HEPATITIS-B VACCINE IN HEALTHY-ADULTS IN SINGAPORE
    GUAN, R
    TAY, HH
    YAP, I
    SMITH, R
    TAN, LH
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1989, 7 (02): : 85 - 88
  • [15] Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults
    Kishino, Hiroyuki
    Takahashi, Kenichi
    Sawata, Miyuki
    Tanaka, Yoshiyuki
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) : 1773 - 1778
  • [16] LONG-TERM IMMUNOGENICITY SAFETY AND EFFICACY OF A RECOMBINANT HEPATITIS-B VACCINE IN HEALTHY-ADULTS
    DENTICO, P
    BUONGIORNO, R
    VOLPE, A
    ZAVOIANNI, A
    PASTORE, G
    SCHIRALDI, O
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 (05) : 650 - 655
  • [17] The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults
    Reuman, PD
    Kubilis, P
    Hurni, W
    Brown, L
    Nalin, D
    VACCINE, 1997, 15 (10) : 1157 - 1161
  • [18] IMMUNOGENICITY OF HEPATITIS-B VIRUS-VACCINE (HEPTAVAX-B) - RESPONSE OF HEALTHY-ADULTS
    BEASLEY, RP
    HWANG, LY
    WESTERN JOURNAL OF MEDICINE, 1984, 140 (05): : 731 - 734
  • [19] RESPONSE TO SUPPLEMENTARY VACCINATION WITH RECOMBINANT OR PLASMA HEPATITIS-B VACCINE IN HEALTHY NON-RESPONDING CHILDREN
    CHENG, KF
    CHANG, MH
    LEE, CY
    HUANG, LM
    HSU, HY
    LEE, PI
    CHEN, CM
    VACCINE, 1994, 12 (10) : 899 - 902
  • [20] A comparative trial of 2 standard S subunit recombinant hepatitis B vaccines versus A S and pre-S subunit vaccine for immunization in healthy adults.
    Eyigun, CP
    Yilmaz, S
    Gul, C
    Sengul, A
    Hacibektasoglu, A
    Colantoni, A
    DeMaria, N
    VanThiel, DH
    HEPATOLOGY, 1997, 26 (04) : 1218 - 1218